AQQRF (Aquarius Surgical Technologies) FCF Yield %: -63.04 (As of Jun. 25, 2026)


What is Aquarius Surgical Technologies FCF Yield %?

Aquarius Surgical Technologies AQQRF FCF Yield % is -63.04 as of Jun. 25, 2026. The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Aquarius Surgical Technologies ranks worse than 93.1% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Aquarius Surgical Technologies's Trailing 12-Month Free Cash Flow is $-0.13 Mil, and Market Cap is $0.20 Mil. Therefore, Aquarius Surgical Technologies's FCF Yield % for today is -63.04%.

The historical rank and industry rank for Aquarius Surgical Technologies's FCF Yield % or its related term are showing as below:

AQQRF' s FCF Yield % Range Over the Past 10 Years
Min: -203.63   Med: -15.94   Max: 31.25
Current: -63.04

During the past 13 years, the highest FCF Yield % of Aquarius Surgical Technologies was 31.25%. The lowest was -203.63%. And the median was -15.94%.

AQQRF's FCF Yield % is ranked worse than
93.1% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: -0.37 vs AQQRF: -63.04

Aquarius Surgical Technologies's FCF Margin % for the quarter that ended in Dec. 2025 was -64.71%.

Aquarius Surgical Technologies FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Aquarius Surgical Technologies FCF Yield % Related Terms

Aquarius Surgical Technologies FCF Yield % Historical Data

* Premium members only.

The historical data trend for Aquarius Surgical Technologies's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aquarius Surgical Technologies FCF Yield % Chart

Aquarius Surgical Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.56 -65.85 5.25 -163.91 -230.34

Aquarius Surgical Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -386.49 -165.64 -106.97 -120.78 -37.96

AQQRF vs ABT, SYK, MDT: FCF Yield % Comparison

For the Medical Devices subindustry, Aquarius Surgical Technologies's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aquarius Surgical Technologies FCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Aquarius Surgical Technologies's FCF Yield % falls into.


Aquarius Surgical Technologies FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Aquarius Surgical Technologies's FCF Yield % for the fiscal year that ended in Mar. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.267 / 0.1159158
=-230.34%

Aquarius Surgical Technologies's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.011 * 4 / 0.1159158
=-37.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -63.04 mean?
Aquarius Surgical Technologies (AQQRF) has a FCF Yield % of -63.04 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Aquarius Surgical Technologies and its competitors. According to the industry distribution chart, Aquarius Surgical Technologies ranks #796 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 93.1%.
Is Aquarius Surgical Technologies' FCF Yield % too high?
Aquarius Surgical Technologies' current FCF Yield % is -63.04. Based on the distribution chart, Aquarius Surgical Technologies ranks #796 out of 855 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Aquarius Surgical Technologies' FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aquarius Surgical Technologies ranks #796 out of 855 companies for FCF Yield %. This places Aquarius Surgical Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Aquarius Surgical Technologies and its competitors. Aquarius Surgical Technologies's current FCF Yield % is -63.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquarius Surgical Technologies stock overvalued right now?
Aquarius Surgical Technologies (AQQRF) has a current FCF Yield % of -63.04. The current FCF Yield % is -63.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Aquarius Surgical Technologies (AQQRF), the current FCF Yield % is -63.04 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aquarius Surgical Technologies Business Description

Other Exchanges ASTI:Canada
Address 89 Scollard Street, Toronto, ON, CAN, M5R 1G4
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments. Through its subsidiary, the company operates as an international distributor, service, and support organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment. Geographically, the company generates maximum revenue from the sale of medical devices in the United States, and also has its presence in Canada.